iPlexus™ – a one stop solution for all relevant information within the pharmaceutical industry. The AI and BLOCKCHAIN powered discovery engine accelerates your drug discovery and research process. Senior executives get real-time data insights on a fingertip for empowered, inspired & faster decisions.

Get the Data on iPlexusTM

35M+

Publications

500K+

Clinical Trials

850K+

Congress Articles

127K+

Drug Profiles

1M+

Dissertations

500+

Patient forums and more

Secured enterprise data

Successfull and failed experiments

Science cannot wait, when patient lives are at stake.

Current state of preclinical research ecosystem

 

  • No means to access and share unpublished experimental data
  • No means to access and share data on failed experiments
  • No mechanism to broadcast IP before publishing in peer reviewed journals

How does iPlexusTM improve it fundamentally?

 

  • Entire published available life science universe with TBs of data in an ontology based knowledge graph
  • Secured platform to share unpublished data on successful and failed experiments
  • Secured IP as experiment broadcasted with an immutable time stamp – AI based guidance valuation of data

Blockchain and AI based iPlexusTM overcomes data silos to make drug discovery more efficient

 

We leverage collective intelligence

Search

Search and access published and

unpublished data based on

concepts, author name etc.

Insights

Gain insights on Discovery and

Preclinical landscape without the peer

review blind spot of 18-24 months

License

Acquire exclusive license to use

other’s work

iPlexusTM: AI based tool for discovery

iPlexusTM  is an innovative and intuitive semantic discovery platform which understands biomedical concepts and allows you to see relevant results in context across multiple data sources like publications, clinical trials, congresses, theses, patents and much more. All in one place, real-time.

 

With iPlexusTM you generate intelligence and insights across pre-clinical, clinical, regulatory and commercial phases of a drug development in a quick, crisp and summarized snapshot with various deep dive opportunities. You can discover most relevant proteins, drugs, diseases, genes and also establish relations between any biomedical entity.  It helps you to make informed and data-backed decisions.

 

Go to iPlexus

#

 

The iPlexusTM Approach

Holistic view of the landscape

with integrated published +

unpublished as well as enterprise

data in a fully secured way

Competitive advantage through

exclusive licensing of unpublished

data. Authors protect IP as their

experimental meta data is

broadcasted immutably

AI based guidance valuation of

unpublished data. Large training

data starts the AGI1 paradigm

Your benefits from iPlexusTM

Strengthening the health care system through practical innovation acceleration and equal opportunities

  • Incentives also for smaller researchers to share even failed experimental data
  • Data enrichment to accelerate innovation, taking data protection into account
  • Increased innovation dynamics for the benefit of the patient

Performance-oriented, objective promoting of research work

  • Secured authorship makes it easier to share even unpublished data
  • Increased innovation efficiency and intelligence due to advanced knowledge base
  • Financing by providing self-failed experimental data

Shorter discovery cycles and cost savings for the life science industry

  • Wider knowledge base through insights into unpublished experiments
  • Insights into the current trend of research and development
  • Cost and time savings through acquisition of results of experiments already performed

Want to learn more about iPlexusTM, discovery and blockchain?

LIFE SCIENCES RESEARCH SIMPLIFIED

We are committed to helping researchers and students from academic institutions experience the power of iPlexusTM.

With our ACADEMIC version, you can start using iPlexusTM at a specially reduced academic pricing.

Know More
Book a Demo